Related Experiment Video
Updated: Sep 15, 2025

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Refinement of TSLP expression mediates chronic allodynia associated with IL22/STAT3 axis
Chun-Ching Lu1, Ying-Yi Lu2, Hung-Pei Tsai3
1Department of Orthopaedics and Traumatology, National Yang Ming Chiao Tung University Hospital, Yilan, 260006, Taiwan; Department of Orthopaedics, School of Medicine, National Yang Ming Chiao Tung University, Taipei, 112304, Taiwan.
Targeting thymic stromal lymphopoietin (TSLP) offers a novel approach to treating chronic pain conditions like allodynia. Inhibiting TSLP reduces neuroinflammation and neuronal loss, potentially alleviating pain by modulating the IL22/STAT3 pathway.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Chronic allodynia results from maladaptive neuroplasticity in the central nervous system.
- Interleukin-22 (IL22) is a key mediator with both pro-inflammatory and immunosuppressive roles.
- Thymic stromal lymphopoietin (TSLP) is implicated in inflammatory and immune responses.
Purpose of the Study:
- To investigate the therapeutic potential of modulating TSLP expression for chronic allodynia.
- To elucidate the mechanisms underlying TSLP's role in allodynia, particularly its interaction with the IL22 pathway.
- To assess the neuroprotective effects of TSLP modulation in vitro.
Main Methods:
- Generated TSLP knockout (KO) mice and compared them with wild-type (WT) mice under bleomycin-induced allodynia conditions.
- Administered bleomycin to induce chronic allodynia and assessed gliosis, neuron loss, and mechanical withdrawal thresholds.
- Utilized differentiated human SH-SY5Y cells to evaluate TSLP's neuroprotective effects against hydrogen peroxide-induced neurotoxicity.
Main Results:
- Bleomycin-induced chronic allodynia in WT mice was associated with reduced IL22/STAT3 pathway activity, increased gliosis, and neuron loss.
- TSLP-deficient mice exhibited significantly reduced gliosis, neuron loss, and altered mechanical withdrawal thresholds compared to WT mice.
- TSLP deficiency protected SH-SY5Y cells from hydrogen peroxide-induced neurotoxicity, and IL22 stimulation further enhanced this protection.
Conclusions:
- A lack of TSLP decreases neuroinflammation, neurotoxicity, and chronic allodynia by downregulating TSLP receptor (TSLPR)/STAT5 and the IL22/STAT3 axis.
- Inhibiting TSLP can rescue the IL22/STAT3-mediated effects, regulating neuroglial interactions to alleviate chronic allodynia.
- Targeting the TSLP/TSLPR pathway presents a promising therapeutic strategy for chronic allodynia by mitigating gliosis, neuron loss, and neuroinflammation.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway

